I. Discovery of Staurosporine
Staurosporine (Str) was discovered in the course of screening for microbial alkaloids in 19771}, of which stucture was elucidated to be an indolo [2,3-a] carbazole (IC) derivative in the next year2 '3) , and has been shown to possess various biological activities, including hypotensive activity and inhibitory activity of platelet aggregation other than antifugal activity soon after its discovery2 '4'5) .
Since Tamaoki et al. reported Str to have potent inhibitory activity for protein kinase C (PKC) in 19866) , it has been a subject of great interest and the number of Str-related reports has increased every year. In particular, in 1992, the number of papers whose titles contain Str reached over 450. Thus, Str became a very important compound, which in used frequently for various biochemical experiments, and its derivatives are potential medicines.
Various kinds of bioactve compounds of microbial origin have been discovered by screening; as a result, the number of newly discovered-substances which are 535 non-antibiotics has been increasing every year7). Since 1990, the ratio of the number of non-antibiotics has exceeded 50% of the total number of secondary metabolites discovered in each year. Under the circumstances, a large number of substances have been identified with Str, because it possesses various activities6 ' 8) .
Consequently, detailed information on biological activities of Str has accumulated. Furthermore, a number of novel IC alkaloids from microorganisms have been discovered especially by high performance liquid chromatography.
Based on these reports, the essential site on the IC skeleton for expression of its activity has been made clear. Thus, the birth of IC alkaloids useful for medicine is expected in parallel with development of research on the relationship between structure and activity of these compounds.
Alkaloid is a name given to naturally occurring nitrogen-containing compounds that possess biological activities. Up to the time that microbial alkaloids, including Str, were discovered by us, the main source of alkalois other than ergot alkaloid had been higher plants. The usual strategy of screening for antibiotics missed other bioactive substances that were produced by microorganisms. Therefore, it was planned to find new substances, and then to examine their biological activities. Based on such concept, the screening of alkaoids produced by microorganisms was begun around 19734).
Briefly, after isolation of small amounts of new Dragendorf-positive compounds, they were examined for various biological activities using small animals or cultured cells. Several alkaloids, including pyrindicin9),
) and ditylomycin14) were discovered to be produced by actinomcetes as well as Str. Furthermore, herquline15) and neoxaline16) were discovered by methods which had been used for detection of fungal alkaloids.
The producing strain of Str (AM-2282) was classified originally to the genus Streptomyces1]'. At present, it has been re-classified to the genus Saccharothrix by various taxonomic studies, including cultural and morphological characteristics and chemical analysis ( 
A. Structure
As Str has highly potent and multiple biological activities, manylaboratories have attempted to -accomplish the total synthesis and to obatin useful derivatives.
However, the absolute configuration of Str remained unclear for a long time; only the relative structure was elucidated by X-ray crystallographic analysis of its methanol solvate by Furusaki et al.2'3\ Recently, Funato et al. determined the absolute configuration of Str by X-ray analysis of crystals of 4/-7V-methylstaurosporine methiodide21), because it was difficult to obtain a suitable crystal of Str itself. As shown in Fig. 2 -A and -B, the X-ray analysis of -TV-methylstaurosporine methiodide reveals the stereochemistry with 2'S, 3'R, A'R, 6'^-configuration and a boat form conformation in the amino sugar moiety. Fromthe results of the X-ray analysis, the absolute stereostructure ( Fig. 2-C) . It is interesting that thd conformation of the amino sugar moiety of compounds 2 and 3 ( Fig. 2-A) having the 4/-ammonium group is the same boat form in both solid and liquid states. This result arises a problem as to which conformation of the amino sugar moiety does protein kinase(s) require, chair or boat form. This problem is very important in the design of more potent and useful inhibitors.
B. Hydrophobicity
As Str is highly hydrophobic and basic, its biochemical activity maydepend on experimental conditions such as the hydrophobicity and pH of the reaction mixture, and on exposure time. These conditions allow and enhance the tight binding of Str to hydrophobic and acidic componentsof cells or tissues. Wedemonstrated that the inhibitory effect on the contraction of rabbit aortic smooth muscle is sustained or even enhanced, even after repeated washing with fresh medium (Fig. 3)22) . Tamaoki et al.6) There is a question as to why Str exhibits a low ability to inhibit platelet aggregation in platelet-rich-plasma (PRP), despite the fact that it is a highly potent inhibitor of PKCand MLCkinase in vitro. An ED50 value of around 10jum exists for platelet aggregation, where Ki values of 4nMand 5nMhave been observed for PKC and MLCkinase, respectively. To study this discrepancy, The strips were contracted with cumulative additions of KC1 (10~60niM) and then exposed to 0.1/jm Str at the point indicated by the arrow. The effect of Str reached a plateau at 60 minutes after its addition. After repeated washing with fresh medium, the contraction of the strip remained suppressed. Platelet-poor plasma (up to 15%of total volume) was added into a reaction mixture containing washed platelets. The reaction mixtures were incubated with 1 fjM Str for 3 minutes and then stimulated by 1fM U46619. Open and closed triangles indicate points of Str and U46619, respectively.
we made use of guinea-pig patelets, washed and in PRP. ED50 value for the inhibition of washed platelets was 50nM, whereas that of platelets in PRP was 10jim. As shown in Fig. 4 , addition of plasma to the reaction mixture containing washed platelets reversed the inhibitory effect of Str (1//m), and 15% plasma almost C. Binding Domain of Str As shown in Fig. 5 , Str inhibits the activities of several protein kinases in a competitive manner with ATP, and the extents ofinhibitory activities are close to each other ( Table 2 ), suggesting that Str is a so-called "non-specific inhibitor". This supposition may result from the fact that the serine/threonine kinases, such as PKC, MLCkinase, cyclic nucleotide-dependent protein kinases and cdc2
kinase, are likely to conserve the amino acid sequence and 3-D structure of the ATP binding domain ( -724) . Our group using computer simulation found that H-7 possibly fits and binds to the phosphate anchor and the part of bottom cleft in the ATP binding domain of PKC (unpublished data.). These results indicate that the binding domain for Str is quite different from that of H-7. As shown in Table 3 , the amino acid sequences of the phosphate anchor and catalytic loop domains seem to be comparatively well conserved among serine/threonine kianses but that of bottom cleft domain is variable. If so, it should be possible to obtain a comparatively specific inhibitor of serine/threonine kinases. In fact, some ATPcompetitive inhibitors were reported to be comparatively specific (Table 2) . To obtain further specific and useful protein Leu-Gly-Lys-Gly-Ser-Phe-Gly-Lys-Val and Leu-Gly-Ser-Gly-Lys-Phe-Gly-Ala-Val, and Arg-AspLeu-Lys-Leu-Asp-Asn and Leu-Asp-Leu-Lys-Pro-GlnAsn, respectively. Therefore, Str has similar Ki values with respect to ATP: 5nM for MLCkinase25) and 4nM
for PKC. Other IC derivatives, such as K-252a26), KT-572027), UCN-0128) and RK-286C29), show a similar tendency, as described in Table 2 . However, substitution of modification of the aglycone moiety modulates the specificity and inhibitory potential of the compounds. KT-5926 having substituent-O(CH2)2CH3 at the 3 position of K-252a was found to be a MLCkinase-specific inhibitor, i.e. it was about 65-fold more potent than with protein kinase A30). Although the precise interaction mechanism of Str at the ATPbinding site of both kinases is not yet known, the ATP binding domain may not require an acidic group in the aglycone moiety of Str. Substitution at the 3 and/or 9 position with the -COOHgroup markedly lowered the inhibitory activity;
Ki values of mono-and di-carboxy-Str for MLCkinase were 416nM and 8^m, respectively (unpublished data). However, substitution at the 3 and/or 9 position with a were not clarified. Thus, it is clear that Str is a potent inhibitor of not only serine/threonine kinases but also tyrosine kinases. JULY 1995 IV. Biological Activities of Staurosporine A. Relaxation of Smooth Muscle Str and IC derivatives inhibit smooth muscle contraction, but the precise inhibitory mechanism is unknown except for the inhibition of MKCkinase30'39). Wereported Str (5~200 nM) to inhibit both intracellular and extracellular Ca2 + dependent contractions of rabbit aortic strips induced by various constrictors (Fig. 6)22 ) and of cultured smooth muscle cells associated with MLCphosphorylation (Fig. 7) including both serine/threonine and tyrosine kinases, and the involvement of these kinases on smooth muscle contraction has been recognized, we must determine whether the inhibitory effect of Str on the contraction is associated with a Str-sensitive mechanism(s) other than MLCkinase or PKC. 
B. Inhibition of Platelet Aggregation
In 1980, the inhibition of platelet aggregation by Str was suggested5) and later this was confirmed experimentally by Oka et al. in 19868) , prior to the discovery of its target protein. Str is now known to widely inhibit various types of platelet aggregatin induced by aggregants, including collagen, thrombin, U46619, epinephrine with similar IC50 values, except for ADP-induced aggregation, as shown in Fig. 8 and Table 4 . Low concentratins of Str (~25nM) exibit little or no effect of ADP-induced aggregation of human washed platelets, whereas this concentration strongly inhibits either 5HT release or aggregation induced by thrombin45). The former reaction seems not to be associated with phospholipase C another effect on intracellular Ca2 + movementin human Platelets were preincubated with Str for 3 minutes before stimulation. Platelet aggregation was induced by addition of 2fig/ml collagen or 1 /im U46619. Open and closed triangles indicate the points of addition of Str and U46619, respectively. almost completely the priming effect of NGFon RNAtranscription of PC12cells, whereas higher concentra-
promoted the rapid generation of neurites in a dose-dependent manner. However, the low concentration promoted neurite generation of NGFprimed PC12 cells50). The neurites ofPC12 cells generated with comparatively high concentrations of Str have a characteristic structure similar to that induced with NGF, as shown in Fig. 10 . The growth corns in cells treated with 60nM Str (Fig. 10-A ; lower picture) and 50ng/ml NGF ( Fig. 10-B ; lower picture) contain numerous electron dense bodies of 90~110nm in diameter and intermediate filaments and microtubular structures, and the neurite objects also contain filamentous structures ( Fig. 10; upper picture) . Recently, Ohmichi et al. found that Str in the range of 10-1000nM inhibits NGFdependent tyrosine phosphorylation of pl40c"trk in PC12
cells51}. Similar results were obtained with another IC derivative, K-252a52). However, it is not completely established that the inhibition of these protein phosphorylations is involved in differentiation and neurite outgrowth of PC12 cells. These results indicate that Str at high concentraions could induce neurite outgrowth through a rearrangement of neurite components, thus act as a low molecular mass neurotrophic factor. Also in the presence of NGF, Str acts Upper picture of each panel shows neurite object and lower one growth corn containing numerous electron dense bodies (90~ll nm).
even at low concentrations.
Weand an other group tried to elucidate the Str effect in vivo, using a numberof experimental systems. Effects of Str on the impairment of learning in rats , in which the basal forebrain was injured with electric heating or ibotenic acid, were studied in Morris' water maje53). Chronic oral administration of Str (0.03~0.1 mg/kg), after the lesion reduced significantly the latent time for the goal, as compared with rats injured but not given Str (Fig. ll) inflammation. Thus, Str or its derivatives may prevent an event occurring after brain hemorrhage followed by ischemia, or prevent some types of dementia.
D. Blocking of Cell Cycle
Str is now known to inhibit a variety of protein kinases in vitro. Amongthem are kinases which are related to the cell growth cycle. In 1988, we demonstrated that low concentrations of Str (10~30 ng/ml) block the transition from the Go to the S phase of cultured rabbit aortic smooth muscle cells stimulated by fetal calf serum56). Theeffective period was within 10 hours after stimulation Str (0.05~0.2mg/kg) was administered for 2 weeks before the task and after each training session. of cells in Go phase to enter Gx phase, probably in the early or middle G1 phase (Fig. 12) . At that time, we did not knowthat Str acted on protein kinases other than PKC. Later, Abe et al. proposed dual actions of Str; low concentrations of Str (l~10ng/ml) arrest cultured fibroblasts at the early Gx phase and high concentrations (100~200ng/ml) at the late G2 phase57). It is reasonable that the most likely target protein is p34cdc2 protein kinase in the early Gx and late G2 phases, rather than PKC, because Str has recently been reported to be a potent inhibitor of cdc2 kinase, and the cdc2à"cyclin B activity seems to increase in the Gx phase and the cdk2 -cyclin A activity in the late G2 phase19). However, we cannot exclude the possibility that Str suppersses the early Gx and/or the late G2-M transition through inhibition of protein kinases other than the cdc2 à" cyclin family as well as PKC. exhibits antitumor activity, but also reverses MDR70) after treatment of CCRF-VCR1000 (a MDRhuman lymphoblastoid cell line expressing Pgp) with a combination of 500nMadriamycin and a non-toxic concentration of 150nM CGP41251 (IC50 for inhibition of cell proliferation: 420 nM CGP4125 i) inhibited cell proliferation ofCCRF-VCR1000 cells by 29%. It was also shown that treatment of CCRF-VCR1000 cells with CGP41251 for 10 minutes is sufficient to inhibit the efflux of rhodamine 123, a substrate of Pgp. Miyamoto et alni) found normal contraction ( Fig. 14) with normal levels of MLC phosphorylation, as observed in non-denuded control artery, whereas the artery bearing intimal thickening exhibited 1.5~1.8-fold extent of contraction with high levels of mono and double phosphorylations of MLC (unpublished data). This arises the possibility that Str or its derivatives might supperss intimal thickening and restenosis after angioplasty, which are the most severe events in blood circulation disease.
